A new five-minute ‘super jab’ that helps to treat 15 different types of cancer is being rolled out across the country.
The NHS is the first in Europe to offer the new injection.
The health service is rolling out an injectable form of immunotherapy, called nivolumab, which means patients can receive their fortnightly or monthly treatment within just five minutes, instead of up to an hour via an IV drip.
The new jab can be used to treat 15 cancer types, including skin cancer, bladder, and oesophagus, and it’s estimated around 1,200 patients in England per month could benefit.
Following the approval from the UK’s medicines regulator, the Medicines and Healthcare products Regulatory Agency (MHRA), it’s said that the roll-out will save more than a year’s worth of treatment time for patients and NHS teams annually, and enable patients to spend less time in hospital while freeing up staff capacity to deliver more appointments and treatments.
In clinical trials, patients were found to be ‘highly satisfied’ with the under-the-skin injection, which takes up to five minutes maximum to administer, and said they much preferred it to the IV form of the drug which takes 30 to 60 minutes every two weeks or four weeks, depending on the cancer type.
Around two in five patients who currently receive IV nivolumab – which is one of the most widely used cancer treatments – should be eligible for the new jab, the NHS has confirmed.
On top of this, most eligible new patients are also expected to begin on the injectable form of nivolumab, rather than the IV.
The NHS is introducing a new five-minute injection for 15 types of cancer, including skin, bladder and oesophageal.
NHS staff administering the jab could save around 1,000 hours of treatment time for patients and clinicians every month.
➡️ https://t.co/gMCtLD3vrZ pic.twitter.com/6iUazTT1jF
— NHS England (@NHSEngland) April 30, 2025
Going forward, NHS cancer services will now be preparing to treat the first patients with the new treatment from next month, which is when supplies of the product are received in the UK, as this will help with the capacity demands in cancer day units, where the drug is currently administered.
“Immunotherapy has already been a huge step forward for many NHS patients with cancer, and being able to offer it as an injection in minutes means we can make the process far more convenient,” commented Professor Peter Johnson, who is NHS England’s National Clinical Director for Cancer.“
This treatment is used for 15 different types of the disease, so it will free up thousands of valuable clinicians’ time every year, allowing teams to treat even more patients and helping hospital capacity.
“And this is just the latest development in the NHS’s ongoing commitment to provide patients with the latest cancer therapies and treatment options that truly transform lives”.
Read more: Eurovision 2025 final to be screened live in cinemas across Leeds
Featured Image – Gustavo Fring (via Unsplash)
